0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Psychopharmacology
 61-80 of 327 Articles
JAMA Psychiatry | 
Neuroscience and Psychiatry | 
Murray B. Stein, MD, MPH; Anne M. Andrews, PhD
JAMA Psychiatry. 2015;72(8):845-847. doi:10.1001/jamapsychiatry.2015.0486.

JAMA Psychiatry | 
Editorial | 
William T. Carpenter Jr, MD; Robert W. Buchanan, MD
JAMA Psychiatry. 2015;72(8):745-746. doi:10.1001/jamapsychiatry.2015.0485.

JAMA Psychiatry | 
Original Investigation | 
Kenneth L. Subotnik, PhD; Laurie R. Casaus, MD; Joseph Ventura, PhD; et al.
JAMA Psychiatry. 2015;72(8):822-829. doi:10.1001/jamapsychiatry.2015.0270.
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Joris Berwaerts, MD; Yanning Liu, MS; Srihari Gopal, MD, MHS; et al.
JAMA Psychiatry. 2015;72(8):830-839. doi:10.1001/jamapsychiatry.2015.0241.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Neuroscience and Psychiatry | 
Paul Newhouse, MD; Kimberly Albert, BS
JAMA Psychiatry. 2015;72(7):727-729. doi:10.1001/jamapsychiatry.2015.0487.

JAMA Psychiatry | 
Original Investigation | 
Peter J. Schmidt, MD; Rivka Ben Dor, MD; Pedro E. Martinez, MD; et al.
JAMA Psychiatry. 2015;72(7):714-726. doi:10.1001/jamapsychiatry.2015.0111.
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Erik Andersson, PhD; Erik Hedman, PhD; Jesper Enander, MSc; et al.
JAMA Psychiatry. 2015;72(7):659-667. doi:10.1001/jamapsychiatry.2015.0546.
Includes: Supplemental Content

JAMA | 
Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2015;313(24):2416. doi:10.1001/jama.2015.6588.

JAMA | 
News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(21):2115. doi:10.1001/jama.2015.5641.

JAMA | 
Original Investigation |  FREE
Krista F. Huybrechts, MS, PhD; Brian T. Bateman, MD, MSc; Kristin Palmsten, ScD; et al.
JAMA. 2015;313(21):2142-2151. doi:10.1001/jama.2015.5605.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Viewpoint | 
Andrew H. Miller, MD; Charles L. Raison, MD
JAMA Psychiatry. 2015;72(6):527-528. doi:10.1001/jamapsychiatry.2015.22.

JAMA Psychiatry | 
Original Investigation |  FREE
Frances R. Levin, MD; John J. Mariani, MD; Sheila Specker, MD; et al.
JAMA Psychiatry. 2015;72(6):593-602. doi:10.1001/jamapsychiatry.2015.41.
Includes: Supplemental Content

JAMA | 
JAMA Clinical Evidence Synopsis | 
Emma Molyneaux, MSc; Kylee Trevillion, PhD; Louise M. Howard, MD, PhD
JAMA. 2015;313(19):1965-1966. doi:10.1001/jama.2015.2276.

JAMA Psychiatry | 
Original Investigation |  FREE
Theodore J. Cicero, PhD; Matthew S. Ellis, MPE
JAMA Psychiatry. 2015;72(5):424-430. doi:10.1001/jamapsychiatry.2014.3043.

JAMA Neurology | 
Viewpoint | 
Kenneth L. Tyler, MD
JAMA Neurol. 2015;72(5):493-494. doi:10.1001/jamaneurol.2014.4625.

JAMA Psychiatry | 
Original Investigation |  FREE
Donovan T. Maust, MD, MS; Hyungjin Myra Kim, ScD; Lisa S. Seyfried, MD, MS; et al.
JAMA Psychiatry. 2015;72(5):438-445. doi:10.1001/jamapsychiatry.2014.3018.

JAMA Psychiatry | 
Original Investigation |  FREE
Annelieke M. Roest, PhD; Peter de Jonge, PhD; Craig D. Williams, PharmD; et al.
JAMA Psychiatry. 2015;72(5):500-510. doi:10.1001/jamapsychiatry.2015.15.
Includes: Supplemental Content

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2015;313(14):1409. doi:10.1001/jama.2015.2563.

JAMA Pediatrics | 
Original Investigation |  FREE ONLINE ONLY
David M. Rubin, MD, MSCE; Amanda R. Kreider, BS, BA; Meredith Matone, MHS; et al.
JAMA Pediatr. 2015;169(4):e150285. doi:10.1001/jamapediatrics.2015.0285.
Includes: Supplemental Content

JAMA Psychiatry | 
Research Letter |  FREE
Stacey C. Sigmon, PhD
JAMA Psychiatry. 2015;72(4):395-396. doi:10.1001/jamapsychiatry.2014.2421.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Research Letter  | 
Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014
Mehmet Burcu, MS; Julie M. Zito, PhD; Leanne Metcalfe, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA Psychiatry
Editorial  | 
What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder
Gerard Sanacora, MD, PhD